Diagonal Bio AB Cash Flow Reinvestment Rate
Diagonal Bio AB cash flow reinvestment rate. Diagonal Bio AB (DIABIO) has a Cash Flow Reinvestment Rate of 0.08x as of March 2024, reinvesting Skr541.00K (capex Skr0.00 plus investments Skr-541.00K) from operating cash flow of Skr6.57 Million. Explore DIABIO cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Diagonal Bio AB (2020–2020)
Cash flow reinvestment rate of Diagonal Bio AB from 2020 to 2020. Historical reinvestment intensity for Diagonal Bio AB across 1 annual periods. Also explore DIABIO net assets growth trend to track the company's year-over-year net asset growth rate.
Diagonal Bio AB Cash Flow Reinvestment Rate by Year (2020–2020)
Diagonal Bio AB cash flow reinvestment rate by year from 2020 to 2020. Year-by-year capital reinvestment analysis for Diagonal Bio AB. For the full cash flow conversion analysis, see how efficiently does Diagonal Bio AB generate cash.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 0.00x | Skr0.00 | Skr226.67K | Skr0.00 | — |